Orally disintegrating dosage forms and taste-masking technologies; 2010

Bibliography

• EMEA, Committee for Medicinal Products for Human Use (CHMP), Reflection Paper: Formulations of Choice for the Paediatric Population, Adoption by CHMP Sept. 21, 2006. Available from: www.emea.europa.eu/pdfs/human/paediatrics/19481005en.pdf [Accessed 20 August 2009]
   Google Scholar
• FDA, Guidance for Industry: Orally Disintegrating Tablets (Rockville, MD, Dec. 2008). Available from: www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2007-D-0365-gdl.pdf [Accessed 20 August 2009]
   Google Scholar
• Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS Pharm Sci Tech 2007;8:E1-7
   PubMedGoogle Scholar
• Goel H, Vora N, Rana V. A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting. AAPS Pharm Sci Tech 2008;9:774-81
   PubMed Web of Science ®Google Scholar
• Douroumis DD, Gryczke A, Schminke S. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets. AAPS Pharm Sci Tech 23 Dec 2010 [Epub ahead of print] DOI: 10.1208/s12249-010-9569-7
   Google Scholar
• Zheng JY, Keeney MP. Taste masking analysis in pharmaceutical formulation development using an electronic tongue. Int J Pharm 2006;310:118-24
   PubMed Web of Science ®Google Scholar
• Li L, Naini V, Ahmed SU. Utilization of a modified special-cubic design and an electronic tongue for bitterness masking formulation optimization. J Pharm Sci 2007;96:2723-34
   PubMed Web of Science ®Google Scholar
• Douroumis D. Practical approaches of taste masking technologies in oral solid forms. Expert Opin Drug Deliv 2007;4:417-26
   PubMed Web of Science ®Google Scholar
• Ghosh TK, Pfister WR. Drug delivery to the oral cavity: molecules to market. Taylor & Francis Group, LLC; Boca Raton 2005
   Google Scholar
• Orellana IG. Strategies to improve oral drug bioavailability. Expert Opin Drug Deliv 2005;2:419-33
   PubMedGoogle Scholar
• Pather SI, Rathbone MJ, Şenel S. Current status and the future of buccal drug delivery systems. Expert Opin Drug Deliv 2008;5:531-42
   PubMed Web of Science ®Google Scholar
• Ayenew Z, Puri V, Kumar L, Bansal AK. Trends in pharmaceutical taste masking technologies: a patent review. Recent Pat Drug Deliv Formul 2009;3:26-39
   PubMedGoogle Scholar
• Jeong SH, Lee J, Woo JS. Fast disintegrating tablets in oral controlled release formulation design and drug delivery: theory to practice. Wiley; New Jersey 2010
   Google Scholar
• R.P Scherer Corp. Method for making freeze dried drug dosage forms. US5631023; 1997
   Google Scholar
• R.P Scherer Corp. Process for preparing solid pharmaceutical dosage forms. US5738875; 1998
   Google Scholar
• Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol 1998;50:375-82
   PubMed Web of Science ®Google Scholar
• Poston KL, Waters C. Zydis selegiline in the management of Parkinson's disease. Expert Opin Pharmacother 2007;8:2615-24
   PubMed Web of Science ®Google Scholar
• Hori H, Ueda N, Yoshimura R, Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study. World J Biol Psychiatry 2009;10:741-5
   PubMed Web of Science ®Google Scholar
• Janssen Pharmaceutica, Inc. Pharmaceutical and other dosage forms. US5648093; 1997
   Google Scholar
• Lafon. Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion. US4616047; 1986
   Google Scholar
• Cima Labs, Inc. Effervescent dosage form with microparticles. US5178878; 1993
   Google Scholar
• Cima Labs, Inc. Rapidly dissolving robust dosage form. US6024981; 2000
   Google Scholar
• Cima Labs, Inc. Pediatric effervescent dosage form. US5223264; 1993
   Google Scholar
• Cima Labs, Inc. Taste masking microparticles for oral dosage forms. US5607697; 1997
   Google Scholar
• Cima Labs, Inc. Rapidly dissolving robust dosage form. US6024981; 2000
   Google Scholar
• Cima Labs, Inc. Taste masking rapid release system. US6740341; 2004
   Google Scholar
• Ethypharm , Inc. Process for manufacturing coated granules with masked taste and immediate release of the active principle. US6660382; 2003
   Google Scholar
• Ethypharm, Inc. Particles with granulated crystalline Ibuprofen. US6951657; 2005
   Google Scholar
• GattefosseTS SA. Tablet for crunching with masked taste and instant release of active principle and method for making same. WO0024385; 2000
   Google Scholar
• Gattefosse ETS SA. Method for coating solid particles with a thermofusible agent and resulting coated solid particles. WO0207706; 2002
   Google Scholar
• Gattefosse ETS SA. Method for preparing a pharmaceutical composition with modified release of the active principle comprising a matrix. WO9814176; 2000
   Google Scholar
• Eurand America, Inc. Effervescent microcapsules. Effervescent microcapsules. US5639475; 1997
   Google Scholar
• Eurand America, Inc. Effervescent microcapsules 5,709,886 ; 1998
   Google Scholar
• Eurand America, Inc. Taste-masked microcapsule compositions and methods of manufacture. US6139865; 2000
   Google Scholar
• Eurand Pharmaceuticals Ltd. Taste masked pharmaceutical compositions prepared by coacervation. WO2006055142; 2006
   Google Scholar
• Kyowa Hakko Kogyo Co. Rotary type tableting machine with lubricant spraying means. US5700492; 1997
   Google Scholar
• Kyowa Hakko Kogyo Co. Process for the production of tablets US6464737; 2002
   Google Scholar
• Fertin Pharma AS. Chewing gum release. WO0213781; 2002
   Google Scholar
• Fertin Pharma AS. Stable medicated chewing gum comprising cyclodextrin inclusion complex. WO2009006898; 2009
   Google Scholar
• Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1-11
   PubMed Web of Science ®Google Scholar
• Guo X, Chang RK, Hussain MA. Ion-exchange resins as drug delivery carriers. J Pharm Sci 2009;98:3886-902
   PubMed Web of Science ®Google Scholar
• McNeil Consumer Products Co. Chewable medicament tablet containing means for taste masking. US4851226; 1989
   Google Scholar
• McNeil Consumer Products Co. Taste masking and sustained release coatings for pharmaceuticals. US5075114; 1991
   Google Scholar
• Ellan Corp. Plc. Controlled release powder and process for its preparation. US4952402; 1990
   Google Scholar
• Fuisz Technologies Ltd. Process and apparatus form making rapidly dissolving dosage units and product there from. US5622719; 1997
   Google Scholar
• Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions. US5869098; 1999
   Google Scholar
• Fuisz Technologies Ltd. Dosage forms containing taste masked active agents. US6165512; 2000
   Google Scholar
• Yamanouchi Pharmaceutical Co., Ltd. Quick release coating preparation. EP0559897; 1992
   Google Scholar
• Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof. US6872405; 2005
   Google Scholar
• Yamanouchi Pharmaceutical Co., Ltd. Tablets quickly disintegrating in the oral cavity and process for producing the same. US6589554; 2003
   Google Scholar
• Crowley MM, Zhang F, Repka MA, Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 2007;33:909-26
   PubMed Web of Science ®Google Scholar
• Repka MA, Battu SK, Upadhye SB, Pharmaceutical applications of hot-melt extrusion: part II. Drug Dev Ind Pharm 2007;33:1043-57
   PubMed Web of Science ®Google Scholar
• Repka MA, Majumdar S, Kumar Battu S, Applications of hot-melt extrusion for drug delivery. Expert Opin Drug Deliv 208;5:1357-76
   PubMed Web of Science ®Google Scholar
• Repka MA, McGinity JW. Influence of Vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. Int J Pharm 2002;202:63-70
   Google Scholar
• Roehm GmbH & Co. Melt extrusion of salts of active ingredients. US20040253314; 2004
   Google Scholar
• Roehm GmbH & Co. Method for producing an immediately decomposing oral form of administration which release active ingredients. US20060051412A1; 2006
   Google Scholar
• Pharma Polymers, 51st International, EUDRAGIT® Workshop; 14 – 16 March 2006; Degussa AG, Business Line Pharma Polymers, Darmstadt, Germany
   Google Scholar
• Cerea M, Zheng W, Young CR, McGinity JW. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. Int J Pharm 2004;279:127-39
   PubMed Web of Science ®Google Scholar
• Reckitt Benckiser Health-Care Ltd. Granules comprising paracetamol a NSAID and a sugar alcohol made by melt extrusion. US20080085308A1; 2008
   Google Scholar
• Fukuda M, Peppas NA, McGinity JW. Floating hot-melt extruded tablets for gastroretentive controlled drug release system. J Control Release 2006;115:121-9
   PubMed Web of Science ®Google Scholar
• Crowley MM, Fredersdorf A, Schroeder B, The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. Eur J Pharm Sci 2004;22:409-18
   PubMed Web of Science ®Google Scholar
• Repka MA, McGinity JW. Physical-mechanical, moisture absorption and bioadhesive properties of hydroxypropylcellulose hot-melt extruded films. Biomaterials 2000;21:1509-17
   PubMed Web of Science ®Google Scholar
• Repka MA, Prodduturi S, Stodghill SP. Production and characterization of hot-melt extruded films containing clotrimazole. Drug Dev Ind Pharm 2003;29:757-65
   PubMed Web of Science ®Google Scholar
• Danjo K, Higuchi F, Otsuka A. Release of lidocaine from polymer film dosage forms. Chem Pharm Bull (Tokyo) 1994;43:1759-63
   Web of Science ®Google Scholar
• Patient information, Chloraseptic relief stripes, cherry, Prestige Brands, International, 2003. Available from: http//www.chloraseptic.com [Last accessed 27 January 2006]
   Google Scholar
• Zengen, Inc. Edible film for relief of cough or symproms associated with pharyngitis. WO2004045537A2; 2004
   Google Scholar
• McNeil-PPC, Inc. Fast dissolving orally consumable films. US7491406; 2009
   Google Scholar
• McNeil-PPC, Inc. Fast dissolving orally consumable films containing a taste masking agent. US7648712; 2010
   Google Scholar
• Lavipharm Laboratories, Inc. Compositions and methods for mucosal delivery. US20030068378A1; 2003
   Google Scholar
• Lavipharm Laboratories, Inc. Intraoral delivery of nicotine for smoking cessation. US20070298090A1; 2007
   Google Scholar
• Lavipharm Laboratories, Inc. Water soluble and palatable complexes. US7125564; 2006
   Google Scholar